We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Approved Fewer New and Orphan Drugs in 2019
The EMA authorized fewer new active substances and orphan drugs in 2019 than in the previous year, according to the agency’s highlights released yesterday.